MedTrace Logo MedTrace
Clinical Trials News Drugs Diseases Companies About

Relapsed or Refractory Acute Leukemia

  1. Home
  2. Diseases
  3. Relapsed or Refractory Acute Leukemia
  4. Clinical Trials

Clinical Trials Related to Relapsed or Refractory Acute Leukemia

Related studies linked through entity extraction aliases.

NCT07722312

S243249 Monotherapy in Patients With Relapsed or Refractory Acute Leukemia With a KMT2A or NUP98 Translocation or Relapsed or Refractory AML With NPM1c Mutation

Status
NOT_YET_RECRUITING
Phase
PHASE1/PHASE2

NCT07696481

Clinical Study on the Safety and Efficacy of PID23 Injection in Patients With Relapsed/Refractory Acute Leukemia

Status
NOT_YET_RECRUITING
Phase
EARLY_PHASE1

NCT03672851

Study Evaluating Safety and Efficacy of CAR-T Cells Targeting CD123 in Patients With Acute Leukemia

Status
TERMINATED
Phase
PHASE1

Clinical Trials

Explore studies by the year of their last update.

  • 2026
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005

News & Analysis

Latest news and insights on clinical trials and medical research.

Browse All News →
MedTrace Logo MedTrace
About Privacy Policy Terms of Service Medical Disclaimer

© 2026 MedTrace.
Open-access medical & pharmaceutical data intelligence.